# clm_A39BDA39B027

subject: Stryker Corporation (/record/stryker.md)  
predicate: quarterly_research_and_development  
value: 413,000,000 United States dollar  
valid_from: 2022-03-31  
valid_to: 2022-06-30  
published: 2022-04-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3F8F3E57B28D  
last_updated: 2026-11-08  
cite: AsOf. "Stryker Corporation quarterly research and development: 413,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_A39BDA39B027, https://asof.is/claim/clm_A39BDA39B027, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2022, filed 2022-04-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm (primary, SEC EDGAR 10-Q Q1 FY2022, published 2022-04-29)

## Supersedes

- [Stryker Corporation](/record/stryker.md) | quarterly_research_and_development | 306,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_A39BDA39B027](/claim/clm_A39BDA39B027.md) | [clm_AE6D661B89B8](/claim/clm_AE6D661B89B8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.